Cerence Inc. (CRNC) stock
CRNCNasdaqServices-Prepackaged SoftwareFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 9/303% below fair value
$7.92−0.24 (-2.94%)
Close on Nov 13, 2026Market cap $358.22MP/E –Yield –
Cerence EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Cerence's EPS for the twelve months ending Jun 30, 2026 was -$0.36. For fiscal 2025 it was -$0.43. The highest annual figure on record is $2.76 in fiscal 2019.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$0.43 | – |
| FY2024 | Sep 30, 2024 | -$14.12 | – |
| FY2023 | Sep 30, 2023 | -$1.40 | – |
| FY2022 | Sep 30, 2022 | -$7.93 | -777.8% |
| FY2021 | Sep 30, 2021 | $1.17 | – |
| FY2020 | Sep 30, 2020 | -$0.50 | -118.1% |
| FY2019 | Sep 30, 2019 | $2.76 | +1625.0% |
| FY2018 | Sep 30, 2018 | $0.16 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $0.03 | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $0.04 | -91.3% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$0.12 | – |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -$0.31 | – |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$0.06 | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $0.46 | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -$0.57 | -207.5% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | -$0.49 | – |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -$7.50 | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$6.66 | – |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $0.53 | – |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -$0.29 | – |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -$0.41 | – |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -$0.65 | – |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -$0.05 | -110.6% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -$5.84 | -3020.0% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -$2.53 | -1786.7% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | -$0.01 | -103.6% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $0.47 | -11.3% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $0.20 | +17.6% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $0.15 | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $0.28 | -17.6% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $0.53 | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $0.17 | -93.5% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -$0.77 | -1640.0% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $0.34 | +3300.0% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -$0.31 | -616.7% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $2.63 | – |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $0.05 | – |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $0.01 | – |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $0.06 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?